CLINICAL_TRIALS
trial_result
· 2010-07-07
Clinical Trial Update: Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication [Phase 2]
Summary
Phase 2 dose-finding study assessing safety and efficacy of NV1FGF in patients with intermittent claudication due to peripheral arterial occlusive disease has c…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Peripheral Arterial Occlusive Disease | Phase 2 | Status: COMPLETED